The global valvular heart diseases market is anticipated to grow at a considerable CAGR of around 8.0% during the forecast period (2024-2031). Valvular heart disease is categorized by deficiency or any damage in one of the four heart valves, namely, aortic, tricuspid or pulmonary, and mitral. Adult cardiac surgery such as treatment for valvular heart diseases is […]
